July 3 (SeeNews) - Bulgarian drug maker Sopharma said on Friday its non-consolidaed sales revenue in the first six months of 2009 rose by 8.0% on the year, backed by robust sales at home.
Sopharma's domestic sales climbed by 11% year-on-year in the first six months of 2009, while exports rose 7.0%, the company said in a statement without giving sales figures.
The drug maker reported parent sales revenue of 86.8 million levs ($62.1 million/44.4 million euro) for the first half of last year.
In June alone Sopharma's sales plunged by an annual 13% after dometic sales dived by 29% due to "a chaos on the pharmacutical market which is shtort-lived", the company said without elaborating.
June exports rose by an anual 1.0%.
Sopharma shares, a component of the benchmark index on the Bulgarian Stock Exchange, lost 3.50% to 2.70 levs on Friday. The statement was published after the end of the trading session.
(1 euro = 1.95583 Bulgarian levs)